Skip to main content
Testing version — LOERadar is in active testing. Features and data may change.
LOERadar
LOE
Radar
Hub
News
Changes
Search
Log in
Get Started
BRENZAVVY (BEXAGLIFLOZIN) | LOERadar
Viewing data from:
Latest
2026-07-01
2026-06-01
2026-05-01
2026-04-01
2026-03-28
2026-02-17
2026-02-10
2025-12-14
2025-02-26
2025-01-25
2024-11-08
2023-07-23
2023-06-15
2023-05-13
2023-01-26
2022-11-22
2022-10-28
2022-09-29
2022-07-09
2022-06-29
2022-04-08
2022-03-09
2021-12-28
2021-05-05
2021-03-12
2020-12-22
2020-11-12
2019-12-14
2019-09-15
BRENZAVVY
NDA
Get alerts
BEXAGLIFLOZIN | N214373 | THERACOSBIO LLC
1 strength
7 unique patents
1 unique exclusivity
Patents
SEC Intel
Revenue
PTAB
Reexams
Litigation
Petitions
Trials
DMF
Approvals
Label
Products
Patent Timeline
7 unique patents, 1 exclusivity by expiration date
Active (7)
Today
Exclusivity
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
Today
7838499
Jan. 30, 2029
8106021
Aug. 22, 2028
8802637
Aug. 22, 2028
8987323
May. 14, 2032
10533032
Jul. 3, 2031
10981942
Jun. 13, 2031
12594243
Oct. 5, 2041
NCE
Jan. 20, 2028
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
No ANDA patent litigation cases (NOS 835) matched from PACER
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (1)
#001 — 20MG
RLD
7 patents
1 exclusivity
▴
TABLET;ORAL | Approved: Jan 20, 2023
Patents (7)
Patent #
Expiration
PED
Drug Substance
Drug Product
Use Code
Delist
7838499
Jan 30, 2029
—
Yes
Yes
U-2214
AN ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIC CONTROL IN ADULTS WITH TYPE 2 DIABETES
—
8106021
Aug 22, 2028
—
—
—
U-2214
AN ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIC CONTROL IN ADULTS WITH TYPE 2 DIABETES
—
8802637
Aug 22, 2028
—
Yes
Yes
U-2214
AN ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIC CONTROL IN ADULTS WITH TYPE 2 DIABETES
—
8987323
May 14, 2032
—
Yes
Yes
—
—
10533032
Jul 3, 2031
—
—
—
U-2214
AN ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIC CONTROL IN ADULTS WITH TYPE 2 DIABETES
—
10981942
Jun 13, 2031
—
Yes
Yes
—
—
12594243
Oct 5, 2041
—
—
Yes
—
—
Exclusivities (1)
Code
Date
Status
NCE
Jan 20, 2028
Active